INKT logo

MiNK Therapeutics (INKT)

Profile

Full Name

MiNK Therapeutics, Inc.

Ticker Symbol

INKT

Exchange

NASDAQ

Country

United States

IPO

October 15, 2021

Indexes

Not included

Employees

23

Key Details

Price

$7.75(+2.49%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.86(+56.27% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 18, 25 HC Wainwright & Co.
Buy
Feb 25, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 15, 24 Baird
Outperform
Oct 9, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
Mar 21, 24 HC Wainwright & Co.
Buy
Aug 10, 23 HC Wainwright & Co.
Buy
May 12, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for MiNK Therapeutics?
  • Does MiNK Therapeutics pay dividends?
  • What sector is MiNK Therapeutics in?
  • What industry is MiNK Therapeutics in?
  • What country is MiNK Therapeutics based in?
  • When did MiNK Therapeutics go public?
  • Is MiNK Therapeutics in the S&P 500?
  • Is MiNK Therapeutics in the NASDAQ 100?
  • Is MiNK Therapeutics in the Dow Jones?
  • When was MiNK Therapeutics's last earnings report?
  • When does MiNK Therapeutics report earnings?
  • Should I buy MiNK Therapeutics stock now?

What is the ticker symbol for MiNK Therapeutics?

The ticker symbol for MiNK Therapeutics is NASDAQ:INKT

Does MiNK Therapeutics pay dividends?

No, MiNK Therapeutics does not pay dividends

What sector is MiNK Therapeutics in?

MiNK Therapeutics is in the Healthcare sector

What industry is MiNK Therapeutics in?

MiNK Therapeutics is in the Biotechnology industry

What country is MiNK Therapeutics based in?

MiNK Therapeutics is headquartered in United States

When did MiNK Therapeutics go public?

MiNK Therapeutics's initial public offering (IPO) was on October 15, 2021

Is MiNK Therapeutics in the S&P 500?

No, MiNK Therapeutics is not included in the S&P 500 index

Is MiNK Therapeutics in the NASDAQ 100?

No, MiNK Therapeutics is not included in the NASDAQ 100 index

Is MiNK Therapeutics in the Dow Jones?

No, MiNK Therapeutics is not included in the Dow Jones index

When was MiNK Therapeutics's last earnings report?

MiNK Therapeutics's most recent earnings report was on Mar 18, 2025

When does MiNK Therapeutics report earnings?

The next expected earnings date for MiNK Therapeutics is May 14, 2025

Should I buy MiNK Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page